NASDAQ:NXGN - Nasdaq - US65343C1027 - Common Stock - Currency: USD
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
A private equity firm is purchasing it at a healthy premium.
/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by NextGen Healthcare, Inc. (NASDAQ: NXGN) and its board of directors...
Overbought stocks are an early indication of a potential correction on a stock; act now if you hold these stocks.
The company agreed to a buyout offer.
Thoma Bravo, a software investment firm, agreed to acquire NextGen Healthcare Inc (NASDAQ: NXGN) for $23.95
Thoma Bravo is in discussions with private credit lenders about arranging roughly $1 billion of debt financing for its planned acquisition of NextGen Healthcare Inc., according to people with knowledge of the matter.
/PRNewswire/ -- Ademi LLP is investigating NextGen Healthcare (Nasdaq: NXGN) for possible breaches of fiduciary duty and other violations of law in its...
Private equity firm Thoma Bravo agreed to acquire patient record software company NextGen Healthcare (NXGN) for $23.95 a share in cash. NextGen rose 15% in premarket trading
Private equity firm Thoma Bravo agreed to acquire patient record software company NextGen Healthcare (NXGN) for $23.95 a share in cash. NextGen rose 15% in premarket trading
Private equity firm Thoma Bravo agree to acquire health-records software company NextGen Healthcare Inc.